Search

Your search keyword '"Johnston, James A"' showing total 4,484 results
Start Over Author "Johnston, James A"
4,484 results on '"Johnston, James A"'

7. Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

Author

Grever, Michael, Andritsos, Leslie, Anghelina, Mirela, Arons, Evgeny, Banerji, Versha, Barrientos, Jacqueline, Bhat, Seema A., Blachly, James, Broccoli, Alessandro, Call, Timothy, Dearden, Claire, Dietrich, Sascha, Else, Monica, Epperla, Narendranath, Fagarasanu, Andrei, Falini, Brunangelo, Forconi, Francesco, Gozzetti, Alessandro, Hampel, Paul, Hermel, David J., Iyengar, Sunil, Johnston, James B., Juliusson, Gunnar, Kreitman, Robert J., Lauria, Francesco, Lozanski, Gerard, Oakes, Christopher C., Parikh, Sameer A., Park, Jae, Quest, Graeme, Rai, Kanti, Ravandi, Farhad, Robak, Tadeusz, Rogers, Kerry A., Saven, Alan, Seymour, John F., Tadmor, Tamar, Tallman, Martin S., Tam, Constantine S., Tiacci, Enrico, Troussard, Xavier, Wörmann, Bernhard, Zent, Clive S., Zenz, Thorsten, and Zinzani, Pier Luigi

Published
2024
Full Text
View/download PDF

9. Non-native plant invasion after fire in western USA varies by functional type and with climate

Author

Prevéy, Janet S., Jarnevich, Catherine S., Pearse, Ian S., Munson, Seth M., Stevens, Jens T., Barrett, Kevin J., Coop, Jonathan D., Day, Michelle A., Firmage, David, Fornwalt, Paula J., Haynes, Katharine M., Johnston, James D., Kerns, Becky K., Krawchuk, Meg A., Miller, Becky A., Nietupski, Ty C., Roque, Jacquilyn, Springer, Judith D., Stevens-Rumann, Camille S., Stoddard, Michael T., and Tortorelli, Claire M.

Published
2024
Full Text
View/download PDF

11. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science

Author

Lilly, Jena V, Rokita, Jo Lynne, Mason, Jennifer L, Patton, Tatiana, Stefankiewiz, Stephanie, Higgins, David, Trooskin, Gerri, Larouci, Carina A, Arya, Kamnaa, Appert, Elizabeth, Heath, Allison P, Zhu, Yuankun, Brown, Miguel A, Zhang, Bo, Farrow, Bailey K, Robins, Shannon, Morgan, Allison M, Nguyen, Thinh Q, Frenkel, Elizabeth, Lehmann, Kaitlin, Drake, Emily, Sullivan, Catherine, Plisiewicz, Alexa, Coleman, Noel, Patterson, Luke, Koptyra, Mateusz, Helili, Zeinab, Van Kuren, Nicholas, Young, Nathan, Kim, Meen Chul, Friedman, Christopher, Lubneuski, Alex, Blackden, Christopher, Williams, Marti, Baubet, Valerie, Tauhid, Lamiya, Galanaugh, Jamie, Boucher, Katie, Ijaz, Heba, Cole, Kristina A, Choudhari, Namrata, Santi, Mariarita, Moulder, Robert W, Waller, Jonathan, Rife, Whitney, Diskin, Sharon J, Mateos, Marion, Parsons, Donald W, Pollack, Ian F, Goldman, Stewart, Leary, Sarah, Caporalini, Chiara, Buccoliero, Anna Maria, Scagnet, Mirko, Haussler, David, Hanson, Derek, Firestein, Ron, Cain, Jason, Phillips, Joanna J, Gupta, Nalin, Mueller, Sabine, Grant, Gerald, Monje-Deisseroth, Michelle, Partap, Sonia, Greenfield, Jeffrey P, Hashizume, Rintaro, Smith, Amy, Zhu, Shida, Johnston, James M, Fangusaro, Jason R, Miller, Matthew, Wood, Matthew D, Gardner, Sharon, Carter, Claire L, Prolo, Laura M, Pisapia, Jared, Pehlivan, Katherine, Franson, Andrea, Niazi, Toba, Rubin, Josh, Abdelbaki, Mohamed, Ziegler, David S, Lindsay, Holly B, Stucklin, Ana Guerreiro, Gerber, Nicolas, Vaske, Olena M, Quinsey, Carolyn, Rood, Brian R, Nazarian, Javad, Raabe, Eric, Jackson, Eric M, Stapleton, Stacie, Lober, Robert M, Kram, David E, Koschmann, Carl, Storm, Phillip B, Lulla, Rishi R, Prados, Michael, Resnick, Adam C, and Waanders, Angela J

Subjects
Neurosciences, Pediatric Cancer, Brain Disorders, Pediatric Research Initiative, Pediatric, Brain Cancer, Rare Diseases, Cancer, Good Health and Well Being, Adult, Humans, Child, Quality of Life, Brain Neoplasms, Collaborative international research infrastructure, Pediatric brain tumors, Multi-omic data, Longitudinal clinical data, Biospecimens, Molecular clinical trials, Clinical Sciences, Oncology & Carcinogenesis
Abstract

Pediatric brain tumors are the leading cause of cancer-related death in children in the United States and contribute a disproportionate number of potential years of life lost compared to adult cancers. Moreover, survivors frequently suffer long-term side effects, including secondary cancers. The Children's Brain Tumor Network (CBTN) is a multi-institutional international clinical research consortium created to advance therapeutic development through the collection and rapid distribution of biospecimens and data via open-science research platforms for real-time access and use by the global research community. The CBTN's 32 member institutions utilize a shared regulatory governance architecture at the Children's Hospital of Philadelphia to accelerate and maximize the use of biospecimens and data. As of August 2022, CBTN has enrolled over 4700 subjects, over 1500 parents, and collected over 65,000 biospecimen aliquots for research. Additionally, over 80 preclinical models have been developed from collected tumors. Multi-omic data for over 1000 tumors and germline material are currently available with data generation for > 5000 samples underway. To our knowledge, CBTN provides the largest open-access pediatric brain tumor multi-omic dataset annotated with longitudinal clinical and outcome data, imaging, associated biospecimens, child-parent genomic pedigrees, and in vivo and in vitro preclinical models. Empowered by NIH-supported platforms such as the Kids First Data Resource and the Childhood Cancer Data Initiative, the CBTN continues to expand the resources needed for scientists to accelerate translational impact for improved outcomes and quality of life for children with brain and spinal cord tumors.

Published
2023

13. Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach

Author

Burman, William, Rucsineanu, Oxana, Horsburgh, C. Robert, Johnston, James, Dorman, Susan E., and Menzies, Dick

Subjects
Antitubercular agents -- Research, Drug resistance in microorganisms -- Research, Tuberculosis -- Drug therapy -- Research, Pharmaceutical research, Biological sciences
Abstract

Author(s): William Burman 1,*, Oxana Rucsineanu 2, C. Robert Horsburgh 3, James Johnston 4, Susan E. Dorman 5, Dick Menzies 6 Brief summary (nonscientific 'standfirst') Despite 25 years of clinical [...]

Published
2024
Full Text
View/download PDF

19. The prevalence of tuberculosis infection among foreign-born Canadians: a modelling study

Author

Jordan, Aria Ed, Houben, Rein M.G.J., Dodd, Peter J., Dale, Katie D., Trauer, James M., Denholm, Justin T., Johnston, James C., Khan, Faiz Ahmad, Campbell, Jonathon R., and Schwartzman, Kevin

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Prevalence studies (Epidemiology) -- Health aspects, Tuberculosis -- Prevention, Rifamycins -- Health aspects, Health, World Health Organization
Abstract

Background: The prevalence of tuberculosis infection is critical to the design of tuberculosis prevention strategies, yet is unknown in Canada. We estimated the prevalence of tuberculosis infection among Canadian residents born abroad. Methods: We estimated the prevalence of tuberculosis infection by age and year of migration to Canada for people from each of 168 countries by constructing country-specific and calendar year-specific trends for annual risk of infection using a previously developed model. We combined country-specific prevalence estimates with Canadian Census data from 2001, 2006, 2011, 2016 and 2021 to estimate the overall prevalence of tuberculosis infection among foreign-born Canadian residents. Results: The estimated overall prevalence of tuberculosis infection among foreign-born people in Canada was 25% (95% uncertainty interval [UI] 20%35%) for census year 2001, 24% (95% UI 20%-33%) for 2006, 23% (95% UI 19%30%) for 2011, 22% (95% UI 19%-28%) for 2016 and 22% (95% UI 19%-27%) for 2021. The prevalence increased with age at migration and incidence of tuberculosis in the country of origin. In 2021, the estimated prevalence of infection among foreign-born residents was lowest in Quebec (19%, 95% UI 16%24%) and highest in Alberta (24%, 95% UI 21%-28%) and British Columbia (24%, 95% UI 20%-30%). Among all foreign-born Canadian residents with tuberculosis infection in 2021, we estimated that only 1 in 488 (95% UI 1851039) had become infected within the 2 preceding years. Interpretation: About 1 in 4 foreign-born Canadian residents has tuberculosis infection, but very few were infected within the 2 preceding years (the highest risk period for progression to tuberculosis disease). These data may inform future tuberculosis infection screening policies., Tuberculosis disease is the leading cause of death by a single infectious agent worldwide, surpassed only by COVID-19 in 2020 and 2021. (1) Tuberculosis disease is preceded by tuberculosis infection, [...]

Published
2023
Full Text
View/download PDF

21. High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial

Author

Ruslami, Rovina, Fregonese, Federica, Apriani, Lika, Barss, Leila, Bedingfield, Nancy, Chiang, Victor, Cook, Victoria J, Fisher, Dina, Flores, Eri, Fox, Greg J, Johnston, James, Lim, Rachel K, Long, Richard, Paulsen, Catherine, Nguyen, Thu Anh, Nhung, Nguyen Viet, Gibson, Diana, Valiquette, Chantal, Benedetti, Andrea, and Menzies, Dick

Published
2024
Full Text
View/download PDF

22. Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trial

Author

Menzies, Dick, Obeng, Joseph, Hadisoemarto, Panji, Ruslami, Rovina, Adjobimey, Menonli, Fisher, Dina, Barss, Leila, Bedingfield, Nancy, Long, Richard, Paulsen, Catherine, Johnston, James, Romanowski, Kamila, Cook, Victoria J., Fox, Greg J., Nguyen, Thu Anh, Valiquette, Chantal, Oxlade, Olivia, Fregonese, Federica, and Benedetti, Andrea

Published
2024
Full Text
View/download PDF

25. The impact of COVID-19 pandemic on global neurosurgery collaborations

Author

Adeleye, Amos Olufemi, Ahmad, Misbahu, Aklilu, Abenezer Tirsit, Blount, Jeffrey, Dewan, Michael, Domeisen, Linda, Endalle, Geneviève, Esene, Ignatius, Faulkner, Kristina, Hong, David, Iaccarino, Corrado, Ikwuegbuenyi, Chibuikem, Johnston, James, Kitya, David, Laeke, Tsegazeab, Mahmud, Muhammad Raji, Muhumuza, Christine, Najjuma, Josephine, Nanda, Anil, Negida, Ahmed, Nketiah-Boakye, Frank, Paiva, Wellingson, Park, Kee, Qureshi, Mahmood, Rock, Jack, Rocque, Brandon, Shabani, Hamisi, Tariq, Muhammad, Tisell, Magnus, Totimeh, Teddy, Zolo-Ossou, André Yvan, Ukachukwu, Alvan-Emeka K., Abu-Bonsrah, Nancy, Seas, Andreas, Petitt, Zoey, Waguia-Kouam, Romaric, Ramos, Samantha, Edwards, Alyssa, Deng, Di D., Haglund, Michael M., and Fuller, Anthony T.

Published
2024
Full Text
View/download PDF

26. Comparing Surgery with and without Duraplasty for Youth with Chiari Malformation Type 1 and Syringomyelia

Author

Limbrick, David, primary, Shannon, Chevis, additional, Bayman, Emine, additional, Kallem, Marisa, additional, Ackerman, Laurie, additional, Adelson, P. David, additional, Ahmed, Raheel, additional, Albert, Gregory, additional, Aldana, Philipp, additional, Alden, Tord, additional, Anderson, Richard, additional, Baird, Lissa, additional, Bauer, David, additional, Bethel-Anderson, Tammy, additional, Bierbrauer, Karin, additional, Brockmeyer, Douglas, additional, Chern, Joshua, additional, Couture, Daniel, additional, Daniels, David, additional, Dauser, Robert, additional, Dlouhy, Brian, additional, Durham, Susan, additional, Ellenbogen, Richard, additional, Eskandari, Ramin, additional, Gannon, Steven, additional, Grant, Gerald, additional, Graupman, Patrick, additional, Greenberg, Jacob, additional, Greene, Stephanie, additional, Greenfield, Jeffrey, additional, Gross, Naina, additional, Guillaume, Daniel, additional, Hankinson, Todd, additional, Iantosca, Mark, additional, Hueur, Gregory, additional, Iskandar, Bermans, additional, Jackson, Eric, additional, Jallo, George, additional, Johnston, James, additional, Keating, Robert, additional, Kelly, Michael, additional, Kennedy, Elaine, additional, Krieger, Mark, additional, Labuda, Rick, additional, Leonard, Jeffrey, additional, Maher, Cormac, additional, Mangano, Francesco, additional, McComb, Gordon, additional, McEvoy, Sean, additional, McKinstry, Robert, additional, Meehan, Thanda, additional, Menezes, Arnold, additional, Niazi, Toba, additional, Oakes, Jerry, additional, Olivarria, Greg, additional, O’Neill, Brent, additional, Poppe, Dorothy, additional, Ragheb, John, additional, Reeves, Samuel, additional, Reynolds, Lisa, additional, Selden, Nathan, additional, Shah, Manish, additional, Shimony, Joshua, additional, Smyth, Matthew, additional, Spears, Sandy, additional, Stone, Scellig, additional, Strahle, Jennifer, additional, Tamber, Mandeep, additional, Tramelli, Gina, additional, Tuite, Gerald, additional, Tyler-Kabara, Elizabeth, additional, Vance, Haley, additional, Wait, Scott, additional, Wellons, John, additional, Whitehead, William, additional, Yahanda, Alexander, additional, Dacey, Ralph, additional, Park, Tae Sung, additional, and Torner, James, additional

Published
2024
Full Text
View/download PDF

28. Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations

Author

Zhao, Shujuan, Mekbib, Kedous Y., van der Ent, Martijn A., Allington, Garrett, Prendergast, Andrew, Chau, Jocelyn E., Smith, Hannah, Shohfi, John, Ocken, Jack, Duran, Daniel, Furey, Charuta G., Hao, Le Thi, Duy, Phan Q., Reeves, Benjamin C., Zhang, Junhui, Nelson-Williams, Carol, Chen, Di, Li, Boyang, Nottoli, Timothy, Bai, Suxia, Rolle, Myron, Zeng, Xue, Dong, Weilai, Fu, Po-Ying, Wang, Yung-Chun, Mane, Shrikant, Piwowarczyk, Paulina, Fehnel, Katie Pricola, See, Alfred Pokmeng, Iskandar, Bermans J., Aagaard-Kienitz, Beverly, Moyer, Quentin J., Dennis, Evan, Kiziltug, Emre, Kundishora, Adam J., DeSpenza, Jr., Tyrone, Greenberg, Ana B. W., Kidanemariam, Seblewengel M., Hale, Andrew T., Johnston, James M., Jackson, Eric M., Storm, Phillip B., Lang, Shih-Shan, Butler, William E., Carter, Bob S., Chapman, Paul, Stapleton, Christopher J., Patel, Aman B., Rodesch, Georges, Smajda, Stanislas, Berenstein, Alejandro, Barak, Tanyeri, Erson-Omay, E. Zeynep, Zhao, Hongyu, Moreno-De-Luca, Andres, Proctor, Mark R., Smith, Edward R., Orbach, Darren B., Alper, Seth L., Nicoli, Stefania, Boggon, Titus J., Lifton, Richard P., Gunel, Murat, King, Philip D., Jin, Sheng Chih, and Kahle, Kristopher T.

Published
2023
Full Text
View/download PDF

40. Molybdenum dichalcogenide cathodes for aluminium-ion batteries

Author

Divya, Shalini, Johnston, James H., and Nann, Thomas

Subjects
Physics - Chemical Physics, Condensed Matter - Mesoscale and Nanoscale Physics, Condensed Matter - Materials Science
Abstract

Many successful battery electrodes are based on 2D-layered materials. We have studied aluminium-ion batteries using molybdenum dichalcogenides: \ce{MoS2}, \ce{MoSe2} and MoSSe as active cathode materials. The batteries showed clear discharge voltage plateaus in the ranges 1.6 - 1.4 V for \ce{MoS2} and \ce{MoSe2}, and 0.6 - 0.5 V for MoSSe. \ce{MoS2} and \ce{MoSe2} have similar crystal structures, interestingly we found that \ce{MoSe2} performed better than \ce{MoS2}. MoSSe exhibited a higher specific capacity over \ce{MoS2} and \ce{MoSe2}, but the energy density was lower than \ce{MoSe2} at a current rate of 40 mA g$^{-1}$. \ce{MoSe2} cells recorded a discharge capacity of $\sim$ 110 mAh g$^{-1}$ with an average potential in the range of 2.0 - 1.8 V and 1.5 - 0.8 V during discharge. The cells were stable at 100 mA g$^{-1}$ for over 200 cycles with 90\% coulombic efficiency., Comment: Energy Technology, 2020

Published
2019
Full Text
View/download PDF

43. Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.

Author

Lucas, Calixto-Hope G, Villanueva-Meyer, Javier E, Whipple, Nicholas, Oberheim Bush, Nancy Ann, Cooney, Tabitha, Chang, Susan, McDermott, Michael, Berger, Mitchel, Cham, Elaine, Sun, Peter P, Putnam, Angelica, Zhou, Hong, Bollo, Robert, Cheshier, Samuel, Poppe, Matthew M, Fung, Kar-Ming, Sung, Sarah, Glenn, Chad, Fan, Xuemo, Bannykh, Serguei, Hu, Jethro, Danielpour, Moise, Li, Rong, Alva, Elizabeth, Johnston, James, Van Ziffle, Jessica, Onodera, Courtney, Devine, Patrick, Grenert, James P, Lee, Julieann C, Pekmezci, Melike, Tihan, Tarik, Bollen, Andrew W, Perry, Arie, and Solomon, David A

Subjects
Lateral Ventricles, Septum Pellucidum, Corpus Callosum, Humans, Glioma, Brain Neoplasms, Cerebral Ventricle Neoplasms, Receptor, Platelet-Derived Growth Factor alpha, Magnetic Resonance Imaging, Mutation, Adolescent, Adult, Aged, Child, Female, Male, Young Adult, High-Throughput Nucleotide Sequencing, White Matter, PDGFRA, DNT-like tumor of the septum pellucidum, corpus callosum, dysembryoplastic neuroepithelial tumor, lateral ventricle, molecular neuro-oncology, molecular neuropathology, myxoid glioneuronal tumor, periventricular white matter, platelet-derived growth factor receptor alpha, septal DNT, septum pellucidum, Neurosciences, Brain Disorders, Cancer, PDGFRA, Clinical Sciences, Neurology & Neurosurgery
Abstract

"Myxoid glioneuronal tumor, PDGFRA p.K385-mutant" is a recently described tumor entity of the central nervous system with a predilection for origin in the septum pellucidum and a defining dinucleotide mutation at codon 385 of the PDGFRA oncogene replacing lysine with either leucine or isoleucine (p.K385L/I). Clinical outcomes and optimal treatment for this new tumor entity have yet to be defined. Here, we report a comprehensive clinical, radiologic, and histopathologic assessment of eight cases. In addition to its stereotypic location in the septum pellucidum, we identify that this tumor can also occur in the corpus callosum and periventricular white matter of the lateral ventricle. Tumors centered in the septum pellucidum uniformly were associated with obstructive hydrocephalus, whereas tumors centered in the corpus callosum and periventricular white matter did not demonstrate hydrocephalus. While multiple patients were found to have ventricular dissemination or local recurrence/progression, all patients in this series remain alive at last clinical follow-up despite only biopsy or subtotal resection without adjuvant therapy in most cases. Our study further supports "myxoid glioneuronal tumor, PDGFRA p.K385-mutant" as a distinct CNS tumor entity and expands the spectrum of clinicopathologic and radiologic features of this neoplasm.

Published
2020

44. Treatment of pediatric high‐grade central nervous system tumors with high‐dose methotrexate in combination with multiagent chemotherapy: A single‐institution experience

Author

Bernstock, Joshua D, Alva, Elizabeth, Cohen, Joshua L, Lobbous, Mina, Chagoya, Gustavo, Elsayed, Galal A, Orr, Brent A, Rozzelle, Curtis, Rocque, Brandon, Blount, Jeffrey, Johnston, James M, Li, Rong, Fiveash, John B, Dhall, Girish, Reddy, Alyssa T, and Friedman, Gregory K

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Pediatric, Neurosciences, Brain Disorders, Rare Diseases, Cancer, Pediatric Cancer, Brain Cancer, Hematology, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Antineoplastic Combined Chemotherapy Protocols, Central Nervous System Neoplasms, Child, Child, Preschool, Cisplatin, Cyclophosphamide, Dose-Response Relationship, Drug, Etoposide, Female, Follow-Up Studies, Humans, Infant, Male, Neoplasm Grading, Retrospective Studies, Survival Rate, Vincristine, ATRT, high-dose chemotherapy, high-dose methotrexate, medulloblastoma, PNET, stem cell rescue, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Oncology and carcinogenesis, Paediatrics
Abstract

BackgroundEffective treatment for pediatric embryonal brain tumors includes dose-intensive multiagent chemotherapy (DIMAC) followed by high-dose chemotherapy with stem cell rescue (HDCSCR). Use of repeated cycles of DIMAC including high-dose methotrexate (HDMTX) without HDCSCR has not been described.ProcedureWe retrospectively reviewed the responses/toxicities in 13 patients (aged 2-155 months, median 22 months) with central nervous system (CNS) tumors (atypical teratoid rhabdoid tumors, CNS embryonal tumors not otherwise specified, pineoblastoma, embryonal tumor with multilayered rosettes, and CNS sarcoma) treated over a 12-year period with repeated cycles of HDMTX followed by etoposide, cisplatin, cyclophosphamide, and vincristine.ResultsSix patients (46.2%) had disseminated disease at presentation and five (38.5%) had gross total resection. A total of 64 courses of therapy were administered with a median of five courses per patient.  Eight patients (61.5%) received radiation therapy (one at relapse). By completion of therapy, 11 patients (84.6%) achieved a response (six complete, five partial).  Six of the 13 patients (46.2%) remain alive with a median follow-up of 48 months (6-146).  Acute toxicities included fever/neutropenia (70.3%), bacteremia (15.6%), and grade 3 mucositis (18.8%).  Long-term complications included learning disability, seizure disorder, and brain necrosis, without treatment-related deaths.ConclusionsDIMAC with HDMTX without HDCSCR may be an effective treatment option for selected patients with embryonal or high-grade CNS tumors.

Published
2020

47. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science

Author

Lilly, Jena V., Rokita, Jo Lynne, Mason, Jennifer L., Patton, Tatiana, Stefankiewiz, Stephanie, Higgins, David, Trooskin, Gerri, Larouci, Carina A., Arya, Kamnaa, Appert, Elizabeth, Heath, Allison P., Zhu, Yuankun, Brown, Miguel A., Zhang, Bo, Farrow, Bailey K., Robins, Shannon, Morgan, Allison M., Nguyen, Thinh Q., Frenkel, Elizabeth, Lehmann, Kaitlin, Drake, Emily, Sullivan, Catherine, Plisiewicz, Alexa, Coleman, Noel, Patterson, Luke, Koptyra, Mateusz, Helili, Zeinab, Van Kuren, Nicholas, Young, Nathan, Kim, Meen Chul, Friedman, Christopher, Lubneuski, Alex, Blackden, Christopher, Williams, Marti, Baubet, Valerie, Tauhid, Lamiya, Galanaugh, Jamie, Boucher, Katie, Ijaz, Heba, Cole, Kristina A., Choudhari, Namrata, Santi, Mariarita, Moulder, Robert W., Waller, Jonathan, Rife, Whitney, Diskin, Sharon J., Mateos, Marion, Parsons, Donald W., Pollack, Ian F., Goldman, Stewart, Leary, Sarah, Caporalini, Chiara, Buccoliero, Anna Maria, Scagnet, Mirko, Haussler, David, Hanson, Derek, Firestein, Ron, Cain, Jason, Phillips, Joanna J., Gupta, Nalin, Mueller, Sabine, Grant, Gerald, Monje-Deisseroth, Michelle, Partap, Sonia, Greenfield, Jeffrey P., Hashizume, Rintaro, Smith, Amy, Zhu, Shida, Johnston, James M., Fangusaro, Jason R., Miller, Matthew, Wood, Matthew D., Gardner, Sharon, Carter, Claire L., Prolo, Laura M., Pisapia, Jared, Pehlivan, Katherine, Franson, Andrea, Niazi, Toba, Rubin, Josh, Abdelbaki, Mohamed, Ziegler, David S., Lindsay, Holly B., Stucklin, Ana Guerreiro, Gerber, Nicolas, Vaske, Olena M., Quinsey, Carolyn, Rood, Brian R., Nazarian, Javad, Raabe, Eric, Jackson, Eric M., Stapleton, Stacie, Lober, Robert M., Kram, David E., Koschmann, Carl, Storm, Phillip B., Lulla, Rishi R., Prados, Michael, Resnick, Adam C., and Waanders, Angela J.

Published
2023
Full Text
View/download PDF

48. Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016

Author

Campbell, Jonathon R., Nsengiyumva, Placide, Chiang, Leslie Y., Jamieson, Frances, Khadawardi, Hadeel, Mah, Henry K.-H., Oxlade, Olivia, Rasberry, Hayden, Rea, Elizabeth, Romanowski, Kamila, Sabur, Natasha F., Sander, Beate, Uppal, Aashna, Johnston, James C., Schwartzman, Kevin, and Brode, Sarah K.

Subjects
Medical care, Cost of -- Statistics, Tuberculosis -- Statistics -- Care and treatment -- Economic aspects, Health
Abstract

After marked declines in tuberculosis (TB) incidence in Canada during the second half of the 20th century (1), progress toward elimination has stalled (2). Although a focus on detection and [...]

Published
2022
Full Text
View/download PDF

50. Going For Olympic Gold: Marketers Hope To Reach The Podium In Paris, Even If Not On The 'Official' Team

Author

Johnston, James J.

Subjects
Olympics -- 2024 AD, Corporate sponsorship -- Laws, regulations and rules -- 2024 AD, Sports marketing -- Laws, regulations and rules -- 2024 AD, Government regulation, Business, international
Abstract

Just about everyone dreams of participating in the Olympics - walking among the parade of nations, being draped with a bronze, silver, or maybe even gold, medal. Most learn at [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results